Correspondence to editorial on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
Saved in:
| Main Authors: | Shunda Du, Karin Wisskirchen, Ke Zhang, Ulrike Protzer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2025-01-01
|
| Series: | Clinical and Molecular Hepatology |
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0781.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reply to correspondence on “Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting”
by: Antonio Bertoletti, et al.
Published: (2025-01-01) -
The effect of enhancers on the lentiviral transduction efficiency in the human RPE cells: Insights for advancing retinal gene therapies
by: Sajad Najafi, et al.
Published: (2025-06-01) -
Hepatitis B surface antigen: carcinogenesis mechanisms and clinical implications in hepatocellular carcinoma
by: Bingyan Hao, et al.
Published: (2025-03-01) -
The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment
by: Lorenzo Carlo Pescatori, et al.
Published: (2025-12-01) -
Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications
by: Huihai Yang, et al.
Published: (2025-07-01)